DOCS
$24.91
Doximity, Inc.
Intraday
Recent News
Assessing Doximity (DOCS) Valuation After A Steep Share Price Pullback
Why Doximity (DOCS) Is Drawing Investor Attention Now Doximity (DOCS) has been on many investors’ watchlists after a steep share price decline over the past year. This has prompted fresh questions about how its current valuation lines up with its financial profile. See our latest analysis for Doximity. At a latest share price of US$24.37, Doximity’s recent pattern includes a 44.42% 3 month share price return decline and a 61.55% 1 year total shareholder return decline. This may indicate...
2 Software Stocks with Solid Fundamentals and 1 We Turn Down
Software is eating the world, and virtually no business is left untouched by it. This secular theme makes SaaS companies attractive investment candidates but also comes with higher valuations that cause volatility. Unfortunately, the rich prices have haunted them over the past six months as the industry has shed 22%. This drop is a far cry from the S&P 500’s 3% ascent.
Doximity's Early 2026 Portal Activity Points to Steady Demand, RBC Says
Doximity (DOCS) is poised to benefit from positive January and February web-traffic trends on its he
Hims and Hers Expands Its Technology Driven Consumer Health Platform
HIMS expands its tech-driven care platform with data-led Labs testing, new menopause and testosterone services and global expansion into Canada.
Atlassian, C3.ai, Doximity, Braze, and Zeta Global Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after investors appeared to buy the dip amid heightened uncertainty triggered by resurgent inflation fears and escalating geopolitical tensions.